The event is powered by
Sartorius BIA Separations
BIA Separations, recently acquired by Sartorius, develops and manufactures market-leading CIM® monolithic chromatographic columns for purification and analysis of large biomolecules, such as viruses, plasmids and mRNA, which are applied in cell and gene therapies. BIA’s technology for manufacturing-scale purification is already used in production of the first commercialized advanced therapeutics; BIA also has a keen presence with novel drug candidates in the clinical pipeline.
They provide products that range from small analytical columns to large industrial prep-scale columns (including cGMP and disposable units) that are extremely simple to use, with no packing of columns needed. In their expanded, fully-equipped BSL 1 and 2 facilities, they support you with process development, analytical method development, or preparation of custom purification media with your ligand of choice.